Does hazelnut consumption affect brain health and function against neurodegenerative diseases?

References

• Willett WC. Diet and health: what should we eat? Science. 1994;264(5158):532–7.
   PubMed Web of Science ®Google Scholar
• Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr. 1991;53(Suppl. 1):189S–93S.
   PubMed Web of Science ®Google Scholar
• Cena H, Calder PC. Defining a healthy diet: evidence for the role of contemporary dietary patterns in health and disease. Nutrients. 2020;12(2):334.
   PubMed Web of Science ®Google Scholar
• Alkhatib A, Tuomilehto J. Lifestyle diabetes prevention. Encyclopedia of endocrine diseases. Cham: Elsevier; 2019. 148–59.
   Google Scholar
• Wiseman MJ. Nutrition and cancer: prevention and survival. Br J Nut. 2019;122(5):481–7.
   PubMed Web of Science ®Google Scholar
• Eilat-Adar S, Sinai T, Yosefy C, Henkin Y. Nutritional recommendations for cardiovascular disease prevention. Nutrients. 2013;5(9):3646–83.
   PubMed Web of Science ®Google Scholar
• Ros E. Health benefits of nut consumption. Nutrients. 2010;2(7):652–82.
   PubMed Web of Science ®Google Scholar
• Essa MM, Qoronfleh MW. Personalized food intervention and therapy for autism spectrum disorder management. Cham: Springer; 2020.
   Google Scholar
• Fischer S, Glei M. Potential health benefits of nuts. Ernahr Umsch. 2013;60(12):206–15.
   Web of Science ®Google Scholar
• Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010;91(1):258S–61S.
   PubMed Web of Science ®Google Scholar
• Mantzoros CS, Williams CJ, Manson JE, Meigs JB, Hu FB. Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am J Clin Nutr. 2006;84(2):328–35.
   PubMed Web of Science ®Google Scholar
• Jackson CL, Hu FB. Long-term associations of nut consumption with body weight and obesity. Am J Clin Nutr. 2014;100(suppl_1):408S–11S.
   PubMed Web of Science ®Google Scholar
• Falasca M, Casari I, Maffucci T. Cancer chemoprevention with nuts. J Natl Cancer Inst. 2014;106(9):dju238.
   PubMedGoogle Scholar
• Bae Y-J, Kim M-H, Choi M-K. Dietary mineral intake from nuts and its relationship to hypertension among Korean adults. Biol Trace Elem Res. 2022;200(8):3519–28.
   PubMed Web of Science ®Google Scholar
• Damasceno NRT, Pérez-Heras A, Serra M, Cofán M, Sala-Vila A, Salas-Salvadó J, et al. Crossover study of diets enriched with virgin olive oil, walnuts or almonds. effects on lipids and other cardiovascular risk markers. Nutr Metab Cardiovasc Dis. 2011;21:S14–S20.
   PubMed Web of Science ®Google Scholar
• Adashek JJ, Redding D. A pilot study on the effects of nut consumption on cardiovascular biomarkers. Cureus. 2020;12(6):1–7.
   Web of Science ®Google Scholar
• Vinson JA, Cai Y. Nuts, especially walnuts, have both antioxidant quantity and efficacy and exhibit significant potential health benefits. Food Funct. 2012;3(2):134–40.
   PubMed Web of Science ®Google Scholar
• Ros E, Sala-Vila A. Nuts and brain health: cognition, depression, and neurodegenerative diseases. Health benefits of nuts and dried fruits. Boca Raton: CRC Press; 2020. p. 261–88.
   Google Scholar
• Przedborski S, Vila M, Jackson-Lewis V. Series introduction: neurodegeneration: what is it and where are we? J Clin Invest. 2003;111(1):3–10.
   PubMed Web of Science ®Google Scholar
• Kovacs GG. Molecular pathology of neurodegenerative diseases: principles and practice. J Clin Pathol. 2019;72(11):725–35.
   PubMed Web of Science ®Google Scholar
• Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10(Suppl 7):S10–S7.
   PubMed Web of Science ®Google Scholar
• Chaudhuri A. Multiple sclerosis is primarily a neurodegenerative disease. J Neural Transm. 2013;120:1463–6.
   PubMed Web of Science ®Google Scholar
• Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease. Mol Neurodegener. 2020;15(1):1–37.
   PubMed Web of Science ®Google Scholar
• Wyss-Coray T, Rogers J. Inflammation in Alzheimer disease—a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med. 2012;2(1):a006346.
   PubMed Web of Science ®Google Scholar
• Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Primers. 2017 Mar 23;3(1):1–21.
   Google Scholar
• Tufekci KU, Meuwissen R, Genc S, Genc K. Inflammation in Parkinson’s disease. Adv Protein Chem Struct Biol. 2012;88:69–132.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang F. Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol. 2017;8:1005.
   PubMed Web of Science ®Google Scholar
• Boĭko A, Favorova O. Multiple sclerosis: molecular and cellular mechanisms. Mol Biol. 1995;29(4):727–49.
   PubMed Web of Science ®Google Scholar
• Walker FO. Huntington’s disease. Lancet. 2007;369(9557):218–28.
   PubMed Web of Science ®Google Scholar
• Joseph J, Cole G, Head E, Ingram D. Nutrition, brain aging, and neurodegeneration. J Neurosci. 2009;29(41):12795–801.
   PubMed Web of Science ®Google Scholar
• Bahaeddin Z, Yans A, Khodagholi F, Hajimehdipoor H, Sahranavard S. Hazelnut and neuroprotection: improved memory and hindered anxiety in response to intra-hippocampal Aβ injection. Nutr Neurosci. 2017;20(6):317–26.
   PubMed Web of Science ®Google Scholar
• Silvestri C, Bacchetta L, Bellincontro A, Cristofori V. Advances in cultivar choice, hazelnut orchard management, and nut storage to enhance product quality and safety: an overview. J Sci Food Agric. 2021;101(1):27–43.
   PubMed Web of Science ®Google Scholar
• Bottone A, Cerulli A, D'Urso G, Masullo M, Montoro P, Napolitano A, et al. Plant specialized metabolites in hazelnut (Corylus avellana) kernel and byproducts: an update on chemistry, biological activity, and analytical aspects. Planta Med. 2019;85(11/12):840–55.
   PubMed Web of Science ®Google Scholar
• Papanastasopoulos P, Stebbing J. Nuts and cancer: where are we now? Lancet Oncol. 2013;14(12):1161.
   PubMed Web of Science ®Google Scholar
• Mehlenbacher SA. Hazelnuts (Corylus). genetic resources of temperate fruit and Nut crops. Acta Hort. 1991;290:63–109.
   Google Scholar
• Dobhal K, Singh N, Semwal A, Negi A. A brief review on: hazelnuts. Int J Recent Sci Res. 2018;9(1):23680–4.
   Google Scholar
• Erdogan V, Mehlenbacher SA. Interspecific hybridization in hazelnut (Corylus). J Am Soc Hortic Sci. 2000;125(4):489–97.
   Web of Science ®Google Scholar
• Germain E. The reproduction of hazelnut (Corylus avellana L.): a review. III Inter Congr Hazelnut 1992 Sep 14;351:195–210.
   Google Scholar
• Organization WH. WHO international standard terminologies on traditional medicine in the western pacific region; 2007.
   Google Scholar
• Organization WH. National policy on traditional medicine and regulation of herbal medicines: report of a WHO global survey. Geneva: World Health Organization; 2005.
   Google Scholar
• Kordafshari G, Kenari HM, Esfahani MM, Ardakani MRS, Keshavarz M, Nazem E, et al. Nutritional aspects to prevent heart diseases in traditional Persian medicine. J Evid Based Complementary Altern Med. 2015;20(1):57–64.
   PubMedGoogle Scholar
• Karimi Z, Firouzi M, Dadmehr M, Javad-Mousavi SA, Bagheriani N, Sadeghpour O. Almond as a nutraceutical and therapeutic agent in Persian medicine and modern phytotherapy: a narrative review. Phytother Res. 2021;35(6):2997–3012.
   PubMed Web of Science ®Google Scholar
• Ibn-e-Sina A. Al-qanun fit-tib [The canon of medicine]. Beirut, Lebanon: Alaalami Beirut lib Press; 2005.
   Google Scholar
• Tajadini H, Choopani R, Saifadini R. Lifestyle methods for prevention of Alzheimer’s disease from the perspective of traditional Persian medicine. J Evid Based Complementary Altern Med. 2016;21(3):243–5.
   PubMedGoogle Scholar
• Iranshahy M, Javadi B. Diet therapy for the treatment of Alzheimer’s disease in view of traditional Persian medicine: a review. Iran J Basic Med Sci. 2019;22(10):1102.
   PubMed Web of Science ®Google Scholar
• Gorji N, Moeini R, Memariani Z. Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer’s disease: a neuropharmacological review of their bioactive constituents. Pharmacol Res. 2018;129:115–27.
   PubMed Web of Science ®Google Scholar
• Borres MP, Sato S, Ebisawa M. Recent advances in diagnosing and managing nut allergies with focus on hazelnuts, walnuts, and cashew nuts. World Allergy Organ J. 2022;15(4):100641.
   PubMedGoogle Scholar
• Şeker ME. Elemental analysis and health risk assessment of different hazelnut varieties (Corylus avellana L.) collected from giresun-Turkey. J Food Compost Anal 2023;122:105475.
   Web of Science ®Google Scholar
• Salvatore MM, Andolfi A, Nicoletti R. Mycotoxin contamination in hazelnut: current status, analytical strategies, and future prospects. Toxins. 2023;15(2):1–21.
   Web of Science ®Google Scholar
• Alasalvar C, Shahidi F, Liyanapathirana CM, Ohshima T. Turkish tombul hazelnut (Corylus avellana L.). 1. Compositional characteristics. J Agric Food Chem. 2003;51(13):3790–6.
   PubMed Web of Science ®Google Scholar
• Alasalvar C, Shahidi F. Tree nuts: Composition, phytochemicals, and health effects. Chapter 12, Compositional characteristics and health effects of hazelnut (Corylus avellana L.). Boca Raton: CRC Press; 2008. p. 199–228.
   Google Scholar
• Brufau G, Boatella J, Rafecas M. Nuts: source of energy and macronutrients. Br J Nutr. 2006;96(S2):S24–S8.
   PubMedGoogle Scholar
• Cosmulescu S, Mihai B, Trandafir I. The mineral source for human nutrition of nuts in different hazelnut (Corylus avellana L.) cultivars. Not Bot Horti Agrobot Cluj Napoca. 2013;41(1):250–4.
   Web of Science ®Google Scholar
• John T, Samuel B, Abolaji O, Folashade O, Oyetooke A, Oluwatosin F. Functional foods and bioactive compounds: roles in the prevention, treatment and management of neurodegenerative diseases. GSC Biol Pharm Sci. 2020;11(2):297–313.
   Google Scholar
• Rai SN, Singh P, Steinbusch HW, Vamanu E, Ashraf G, Singh MP. The role of vitamins in neurodegenerative disease: an update. Biomedicines. 2021;9(10):1284.
   PubMed Web of Science ®Google Scholar
• DeSalvo KB, Olson R, KO C. Dietary guidelines for Americans. Jama. 2016;315(5):457–8.
   PubMed Web of Science ®Google Scholar
• Taş NG, Gökmen V. Profiling triacylglycerols, fatty acids and tocopherols in hazelnut varieties grown in Turkey. J Food Compost Anal. 2015;44:115–21.
   Web of Science ®Google Scholar
• Bălașa AF, Chircov C, Grumezescu AM. Marine biocompounds for neuroprotection—a review. Mar Drugs. 2020;18(6):290.
   PubMed Web of Science ®Google Scholar
• Delgado-Zamarreño MM, Fernández-Prieto C, Bustamante-Rangel M, Pérez-Martín L. Determination of tocopherols and sitosterols in seeds and nuts by QuEChERS-liquid chromatography. Food Chem. 2016;192:825–30.
   PubMed Web of Science ®Google Scholar
• Fang F, HO CT, Sang S, Rosen RT. Determination of sphingolipids in nuts and seeds by a single quadrupole liquid chromatography–mass spectrometry method. J Food Lipids. 2005;12(4):327–43.
   Google Scholar
• Włodarek D. Role of ketogenic diets in neurodegenerative diseases (Alzheimer’s disease and Parkinson’s disease). Nutrients. 2019;11(1):169.
   PubMed Web of Science ®Google Scholar
• Alessenko AV, Albi E. Exploring sphingolipid implications in neurodegeneration. Front Neurol. 2020;11:437.
   PubMed Web of Science ®Google Scholar
• Bhagwat S, Haytowitz DB, Holden JM. USDA database for the flavonoid content of selected foods, release 3. Beltsville, MD, USA: US department of agriculture; 2011, 159.
   Google Scholar
• Bolling BW, McKay DL, Blumberg JB. The phytochemical composition and antioxidant actions of tree nuts. Asia Pac J Clin Nutr. 2010;19(1):117.
   PubMed Web of Science ®Google Scholar
• Jakopic J, Petkovsek MM, Likozar A, Solar A, Stampar F, Veberic R. HPLC–MS identification of phenols in hazelnut (Corylus avellana L.) kernels. Food Chem. 2011;124(3):1100–6.
   Web of Science ®Google Scholar
• Daglia M, Di Lorenzo A, Nabavi F, Talas ZS, Nabavi ZM. Polyphenols: well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat! Curr Pharm Biotechnol. 2014;15(4):362–72.
   PubMed Web of Science ®Google Scholar
• Singh NA, Mandal AKA, Khan ZA. Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG). Nutr J. 2015;15:1–17.
   Web of Science ®Google Scholar
• Sun W, Shahrajabian MH, Cheng Q. Epigallocatechin gallate, a unique natural compound with tremendous health benefits. ROCE. 2019;14(1):52–64.
   Google Scholar
• Köksal Aİ, Artik N, Şimşek A, Güneş N. Nutrient composition of hazelnut (Corylus avellana L.) varieties cultivated in Turkey. Food Chem. 2006;99(3):509–15.
   Web of Science ®Google Scholar
• Venkatachalam M, Sathe SK. Chemical composition of selected edible nut seeds. J Agric Food Chem. 2006;54(13):4705–14.
   PubMed Web of Science ®Google Scholar
• Fernandes GD, Gómez-Coca RB, Pérez-Camino M, Moreda W, Barrera-Arellano D. Chemical characterization of major and minor compounds of nut oils: almond, hazelnut, and pecan nut. J. Chem. 2017;2017:1–11.
   Web of Science ®Google Scholar
• Di Michele A, Pagano C, Allegrini A, Blasi F, Cossignani L, Raimo ED, et al. Hazelnut shells as source of active ingredients: extracts preparation and characterization. Molecules. 2021;26(21):6607.
   PubMed Web of Science ®Google Scholar
• Yuan B, Lu M, Eskridge KM, Isom LD, Hanna MA. Extraction, identification, and quantification of antioxidant phenolics from hazelnut (Corylus avellana L.) shells. Food Chem. 2018;244:7–15.
   PubMed Web of Science ®Google Scholar
• Smith MA. Alzheimer disease. Int Rev Neurobiol. 1998;42:1–54.
   PubMed Web of Science ®Google Scholar
• Rajasekhar K, Chakrabarti M, Govindaraju T. Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer’s disease. Chem Commun. 2015;51(70):13434–50.
   PubMed Web of Science ®Google Scholar
• Gadhave K, Kumar D, Uversky VN, Giri R. A multitude of signaling pathways associated with Alzheimer’s disease and their roles in AD pathogenesis and therapy. Med Res Rev. 2021;41(5):2689–745.
   PubMed Web of Science ®Google Scholar
• Muralidar S, Ambi SV, Sekaran S, Thirumalai D, Palaniappan B. Role of tau protein in Alzheimer's disease: the prime pathological player. Int J Biol Macromol. 2020;163:1599–617.
   PubMed Web of Science ®Google Scholar
• Iqbal K, Gong C-X, Liu F. Hyperphosphorylation-induced tau oligomers. Front Neurol. 2013;4:112.
   PubMed Web of Science ®Google Scholar
• Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem. 2008;283(44):29615–9.
   PubMed Web of Science ®Google Scholar
• O’brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer’s disease. Annu Rev Neurosci. 2011;34:185.
   PubMed Web of Science ®Google Scholar
• Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ. Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity: a potent role for trimers. J Physiol. 2006;572(2):477–92.
   PubMed Web of Science ®Google Scholar
• Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr. 2000;71(2):621S–9S.
   PubMed Web of Science ®Google Scholar
• Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA. Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol. 2006;65(7):631–41.
   PubMed Web of Science ®Google Scholar
• Gella A, Durany N. Oxidative stress in Alzheimer disease. Cell Adh Migr. 2009;3(1):88–93.
   PubMed Web of Science ®Google Scholar
• Meraz-Ríos MA, Toral-Rios D, Franco-Bocanegra D, Villeda-Hernández J, Campos-Peña V. Inflammatory process in Alzheimer’s disease. Front. Integr. Neurosci. 2013;7:59.
   PubMedGoogle Scholar
• Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015;16(6):358–72.
   PubMed Web of Science ®Google Scholar
• Luchsinger JA, Mayeux R. Dietary factors and Alzheimer’s disease. Lancet Neurol. 2004;3(10):579–87.
   PubMed Web of Science ®Google Scholar
• Koppal T, Subramaniam R, Drake J, Prasad MR, Dhillon H, Butterfield DA. Vitamin E protects against Alzheimer’s amyloid peptide (25–35)-induced changes in neocortical synaptosomal membrane lipid structure and composition. Brain Res. 1998;786(1-2):270–3.
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, et al. Diet and Alzheimer’s disease risk factors or prevention: the current evidence. Expert Rev Neurother. 2011;11(5):677–708.
   PubMed Web of Science ®Google Scholar
• Trichopoulou A, Lagiou P. Healthy traditional Mediterranean diet: an expression of culture, history, and lifestyle. Nutr Rev. 1997;55(11):383–9.
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, Colacicco AM, D’Introno A, Capurso C, Torres F, Rizzo C, et al. Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian longitudinal study on aging. Neurobiol Aging. 2006;27(11):1694–704.
   PubMed Web of Science ®Google Scholar
• Boudrault C, Bazinet RP, Ma DW. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer’s disease. J Nutr Biochem. 2009;20(1):1–10.
   PubMed Web of Science ®Google Scholar
• Gwon A-R, Park J-S, Park J-H, Baik S-H, Jeong H-Y, Hyun D-H, et al. Selenium attenuates Aβ production and Aβ-induced neuronal death. Neurosci Lett. 2010;469(3):391–5.
   PubMed Web of Science ®Google Scholar
• Brickman AM, Khan UA, Provenzano FA, Yeung L-K, Suzuki W, Schroeter H, et al. Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults. Nat Neurosci. 2014;17(12):1798–803.
   PubMed Web of Science ®Google Scholar
• Phan HT, Samarat K, Takamura Y, Azo-Oussou AF, Nakazono Y, MdC V. Polyphenols modulate Alzheimer’s amyloid beta aggregation in a structure-dependent manner. Nutrients. 2019;11(4):756.
   PubMed Web of Science ®Google Scholar
• Ayaz M, Sadiq A, Junaid M, Ullah F, Ovais M, Ullah I, et al. Flavonoids as prospective neuroprotectants and their therapeutic propensity in aging associated neurological disorders. Front Aging Neurosci. 2019;11:155.
   PubMed Web of Science ®Google Scholar
• Bolling BW, Chen C-YO, McKay DL, Blumberg JB. Tree nut phytochemicals: composition, antioxidant capacity, bioactivity, impact factors. A systematic review of almonds, Brazils, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios and walnuts. Nutr Res Rev. 2011;24(2):244–75.
   PubMed Web of Science ®Google Scholar
• Schroeter H, Spencer JP, Rice-Evans C, Williams RJ. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J. 2001;358(3):547–57.
   PubMedGoogle Scholar
• Hussain G, Zhang L, Rasul A, Anwar H, Sohail MU, Razzaq A, et al. Role of plant-derived flavonoids and their mechanism in attenuation of Alzheimer’s and Parkinson’s diseases: an update of recent data. Molecules. 2018;23(4):814.
   PubMed Web of Science ®Google Scholar
• Vafeiadou K, Vauzour D, Lee HY, Rodriguez-Mateos A, Williams RJ, Spencer JP. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch Biochem Biophys. 2009;484(1):100–9.
   PubMed Web of Science ®Google Scholar
• Spencer JP, Vafeiadou K, Williams RJ, Vauzour D. Neuroinflammation: modulation by flavonoids and mechanisms of action. Mol Aspects Med. 2012;33(1):83–97.
   PubMed Web of Science ®Google Scholar
• Wang L, Zeng R, Pang X, Gu Q, Tan W. The mechanisms of flavonoids inhibiting conformational transition of amyloid-β 42 monomer: a comparative molecular dynamics simulation study. RSC Adv. 2015;5(81):66391–402.
   Web of Science ®Google Scholar
• Ramezani M, Meymand AZ, Khodagholi F, Kamsorkh HM, Asadi E, Noori M, et al. A role for flavonoids in the prevention and/or treatment of cognitive dysfunction, learning, and memory deficits: a review of preclinical and clinical studies. Nutr Neurosci. 2022;156–172:1–17.
   Google Scholar
• Lagoa R, Graziani I, Lopez-Sanchez C, Garcia-Martinez V, Gutierrez-Merino C. Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria. Biochim Biophys Acta Bioenerg. 2011;1807(12):1562–72.
   Web of Science ®Google Scholar
• Glenn JM, Madero EN, Bott NT. Dietary protein and amino acid intake: links to the maintenance of cognitive health. Nutrients. 2019;11(6):1315.
   PubMed Web of Science ®Google Scholar
• Balestrino R, Schapira A. Parkinson disease. Eur J Neurol. 2020;27(1):27–42.
   PubMed Web of Science ®Google Scholar
• Schroeders U, Zimmermann J, Wicke T, Schaumburg M, Lang E, Trenkwalder C, et al. Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease. Neuropsychology. 2022;36(4):266–78.
   PubMed Web of Science ®Google Scholar
• Zhang TM, Yu SY, Guo P, Du Y, Hu Y, Piao YS, et al. Nonmotor symptoms in patients with Parkinson disease: a cross-sectional observational study. Medicine. 2016;95(50):e5400.
   PubMed Web of Science ®Google Scholar
• Dexter DT, Jenner P. Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med. 2013;62:132–44.
   PubMed Web of Science ®Google Scholar
• Mullin S, Schapira AH. Pathogenic mechanisms of neurodegeneration in Parkinson disease. Neurol Clin. 2015;33(1):1–17.
   PubMed Web of Science ®Google Scholar
• Kam T-I, Hinkle JT, Dawson TM, Dawson VL. Microglia and astrocyte dysfunction in Parkinson’s disease. Neurobiol Dis. 2020;144:105028.
   PubMed Web of Science ®Google Scholar
• Knight E, Geetha T, Burnett D, Babu JR. The role of diet and dietary patterns in Parkinson’s disease. Nutrients. 2022;14(21):4472.
   PubMed Web of Science ®Google Scholar
• Ghiglieri V, Calabrese V, Calabresi P. Alpha-synuclein: from early synaptic dysfunction to neurodegeneration. Front Neurol. 2018;9:295.
   PubMed Web of Science ®Google Scholar
• Javed H, Nagoor Meeran MF, Azimullah S, Adem A, Sadek B, Ojha SK. Plant extracts and phytochemicals targeting α-synuclein aggregation in Parkinson’s disease models. Front Pharmacol. 2019;9:1555.
   PubMed Web of Science ®Google Scholar
• Magalingam KB, Radhakrishnan AK, Haleagrahara N. Protective mechanisms of flavonoids in Parkinson’s disease. Oxid Med Cell Longev. 2015;2015:1–14.
   Web of Science ®Google Scholar
• Shen L. Associations between B vitamins and Parkinson’s disease. Nutrients. 2015;7(9):7197–208.
   PubMed Web of Science ®Google Scholar
• Ellwanger JH, Franke SI, Bordin DL, Pra D, Henriques JA. Biological functions of selenium and its potential influence on Parkinson’s disease. An Acad Bras Cienc. 2016;88:1655–74.
   PubMed Web of Science ®Google Scholar
• Ellwanger JH, Molz P, Dallemole DR, dos Santos AP, Müller TE, Cappelletti L, et al. Selenium reduces bradykinesia and DNA damage in a rat model of Parkinson’s disease. Nutrition. 2015;31(2):359–65.
   PubMed Web of Science ®Google Scholar
• De Lau L, Bornebroek M, Witteman J, Hofman A, Koudstaal P, Breteler M. Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology. 2005;64(12):2040–5.
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Nishi K, Nagasao J, Tsuji S, Oyanagi K. Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP+) toxicity in dopaminergic neurons. Brain Res. 2008;1197:143–51.
   PubMed Web of Science ®Google Scholar
• Miyake Y, Tanaka K, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, et al. Dietary intake of metals and risk of Parkinson's disease: a case-control study in Japan. J Neurol Sci. 2011;306(1–2):98–102.
   PubMed Web of Science ®Google Scholar
• Boillée S, Velde CV, Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52(1):39–59.
   PubMed Web of Science ®Google Scholar
• Clarke BE, Patani R. The microglial component of amyotrophic lateral sclerosis. Brain. 2020;143(12):3526–39.
   PubMedGoogle Scholar
• Cho H, Shukla S. Role of edaravone as a treatment option for patients with amyotrophic lateral sclerosis. Pharmaceuticals. 2020;14(1):29.
   Web of Science ®Google Scholar
• Klemann CJ, Visser JE, Van Den Bosch L, Martens G, Poelmans G. Integrated molecular landscape of amyotrophic lateral sclerosis provides insights into disease etiology. Brain Pathol 2018;28(2):203–11.
   PubMed Web of Science ®Google Scholar
• Jin Y, Oh K, Oh S-i, Baek H, Kim SH, Park Y. Dietary intake of fruits and beta-carotene is negatively associated with amyotrophic lateral sclerosis risk in Koreans: a case-control study. Nutr Neurosci. 2014;17(3):104–8.
   PubMed Web of Science ®Google Scholar
• Okamoto K, Kihira T, Kobashi G, Washio M, Sasaki S, Yokoyama T, et al. Fruit and vegetable intake and risk of amyotrophic lateral sclerosis in Japan. Neuroepidemiology. 2009;32(4):251–6.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Song J, Zhang M, Wang H, Zhang Y, Suo H. Comparison of in vitro and in vivo antioxidant activities of six flavonoids with similar structures. Antioxidants. 2020;9(8):732.
   Web of Science ®Google Scholar
• Pazdro R, Burgess JR. The role of vitamin E and oxidative stress in diabetes complications. Mech Ageing Dev. 2010;131(4):276–86.
   PubMed Web of Science ®Google Scholar
• Hong J-H, Kim M-J, Park M-R, Kwag O-G, Lee I-S, Byun BH, et al. Effects of vitamin E on oxidative stress and membrane fluidity in brain of streptozotocin-induced diabetic rats. Clin Chim Acta. 2004;340(1–2):107–15.
   PubMed Web of Science ®Google Scholar
• Veldink JH, Kalmijn S, Groeneveld G-J, Wunderink W, Koster A, de Vries JH, et al. Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2007;78(4):367–71.
   PubMed Web of Science ®Google Scholar
• Ginanjar E, Setiati S, Setiyohadi B. Vitamin D and autoimmune disease. Acta Med Indones. 2007;39(3):133–41.
   PubMedGoogle Scholar
• Khan H, Sureda A, Belwal T, Çetinkaya S, Süntar İ, Tejada S, et al. Polyphenols in the treatment of autoimmune diseases. Autoimmun Rev. 2019;18(7):647–57.
   PubMed Web of Science ®Google Scholar
• Li X, Bi X, Wang S, Zhang Z, Li F, Zhao AZ. Therapeutic potential of ω−3 polyunsaturated fatty acids in human autoimmune diseases. Front Immunol; 2019;10:2241.
   PubMed Web of Science ®Google Scholar
• Xia K, Wang Y, Zhang L, Tang L, Zhang G, Huang T, et al. Dietary-derived essential nutrients and amyotrophic lateral sclerosis: a two-sample Mendelian randomization study. Nutrients. 2022;14(5):920.
   PubMed Web of Science ®Google Scholar
• Guan J-Z, Guan W-P, Maeda T. Vitamin E administration erases an enhanced oxidation in multiple sclerosis. Can J Physiol Pharmacol. 2018;96(11):1181–3.
   PubMed Web of Science ®Google Scholar
• Goldenberg MM. Multiple sclerosis review. Pharm Therapeutic. 2012;37(3):175.
   Google Scholar
• Gilgun-Sherki Y, Melamed E, Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol. 2004;251(3):261–8.
   PubMed Web of Science ®Google Scholar
• Zéphir H. Progress in understanding the pathophysiology of multiple sclerosis. Rev Neurol. 2018;174(6):358–63.
   PubMedGoogle Scholar
• Voet S, Prinz M, van Loo G. Microglia in central nervous system inflammation and multiple sclerosis pathology. Trends Mol Med. 2019;25(2):112–23.
   PubMed Web of Science ®Google Scholar
• Evers I, Heerings M, de Roos N, Jongen P, Visser L. Adherence to dietary guidelines is associated with better physical and mental quality of life: results from a cross-sectional survey among 728 Dutch MS patients. Nutr Neurosci. 2022;25(8):1633–40.
   PubMed Web of Science ®Google Scholar
• Payne A. Nutrition and diet in the clinical management of multiple sclerosis. J Hum Nutr Diet. 2001;14(5):349–57.
   PubMed Web of Science ®Google Scholar
• Swank R, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet. 1990;336(8706):37–9.
   PubMed Web of Science ®Google Scholar
• Mische LJ, Mowry EM. The evidence for dietary interventions and nutritional supplements as treatment options in multiple sclerosis: a review. Curr Treat Options Neurol. 2018;20(4):1–11.
   PubMed Web of Science ®Google Scholar
• Bayat P, Farshchi M, Yousefian M, Mahmoudi M, Yazdian-Robati R. Flavonoids, the compounds with anti-inflammatory and immunomodulatory properties, as promising tools in multiple sclerosis (MS) therapy: a systematic review of preclinical evidence. Int Immunopharmacol. 2021;95:107562.
   PubMed Web of Science ®Google Scholar
• Toledo J, Fraga-Silva T, Borim PA, De Oliveira LRC, Oliveira E, Périco LL, et al. Organic selenium reaches the central nervous system and downmodulates local inflammation: A complementary therapy for multiple sclerosis? Front Immunol. 2020;11:571844.
   PubMed Web of Science ®Google Scholar
• Calderón-Ospina CA, Nava-Mesa MO. B vitamins in the nervous system: current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin. CNS Neurosci Ther. 2020;26(1):5–13.
   PubMed Web of Science ®Google Scholar
• Collins G. Glial cell changes in the brain stem of thiamine-deficient rats. Am. J. Pathol. 1967;50(5):791.
   PubMed Web of Science ®Google Scholar
• Schwarz S, Leweling H. Multiple sclerosis and nutrition. Mult Scler J. 2005;11(1):24–32.
   PubMed Web of Science ®Google Scholar
• Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology. 1994;44(9):1687.
   PubMed Web of Science ®Google Scholar
• Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington disease. Nat Rev Dis Primers. 2015;1(1):1–21.
   Google Scholar
• Palpagama TH, Waldvogel HJ, Faull RL, Kwakowsky A. The role of microglia and astrocytes in Huntington’s disease. Front Mol Neurosci. 2019;12:258.
   PubMed Web of Science ®Google Scholar
• Ghosh R, Tabrizi SJ. Huntington disease. Handb Clin Neurol. 2018;147:255–78.
   PubMedGoogle Scholar
• Żukiewicz-Sobczak W, Król R, Wróblewska P, Piątek J, Gibas-Dorna M. Huntington disease–principles and practice of nutritional management. Neurol Neurochir Pol. 2014;48(6):442–8.
   PubMed Web of Science ®Google Scholar
• Khan F, Garg V, Singh A, Kumar T. Role of free radicals and certain antioxidants in the management of Huntington’s disease: a review. J Anal Pharm Res. 2018;7:386–92.
   Google Scholar
• Miyamoto M, Murphy TH, Schnaar RL, Coyle JT. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J Pharmacol Exp Ther. 1989;250(3):1132–40.
   PubMed Web of Science ®Google Scholar
• Cong W, Bai R, Li Y-F, Wang L, Chen C. Selenium nanoparticles as an efficient nanomedicine for the therapy of Huntington’s disease. ACS Appl Mater Interfaces. 2019;11(38):34725–35.
   PubMed Web of Science ®Google Scholar
• Khan H, Ullah H, Tundis R, Belwal T, Devkota HP, Daglia M, et al. Dietary flavonoids in the management of Huntington’s disease: mechanism and clinical perspective. EFood. 2020;1(1):38–52.
   Google Scholar
• Sandhir R, Mehrotra A. Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington’s disease. Biochim Biophys Acta Mol Basis Dis. 2013;1832(3):421–30.
   Web of Science ®Google Scholar
• Olofinnade AT, Onaolapo AY, Onaolapo OJ, Olowe OA, Mollica A, Zengin G, et al. Corylus avellana L. modulates neurobehaviour and brain chemistry following high-fat diet. Front Biosci. 2020;26(3):537–51.
   Web of Science ®Google Scholar
• Olofinnade AT, Onaolapo AY, Onaolapo OJ, Olowe OA. Hazelnut modulates neurobehaviour and ameliorates ageing-induced oxidative stress, and caspase-3-mediated apoptosis in mice. Curr Aging Sci. 2021;14(2):154–62.
   PubMedGoogle Scholar
• Radi E, Formichi P, Battisti C, Federico A. Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimers Dis. 2014;42(s3):S125–S52.
   PubMedGoogle Scholar
• Esposito L, Raber J, Kekonius L, Yan F, Yu G-Q, Bien-Ly N, et al. Reduction in mitochondrial superoxide dismutase modulates Alzheimer’s disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci. 2006;26(19):5167–79.
   PubMed Web of Science ®Google Scholar
• White N, Naldoza-Drake P, Black K, Scullion L, Machado L. Can improving the nutritional content of bread enhance cognition? Cognitive outcomes from a randomized controlled trial. J Cogn Enhanc. 2020;4:167–78.
   Google Scholar
• Codella R, Benedini S, Paini S, Caumo A, Adamo M, Terruzzi I, et al. Effect of sugar versus mixed breakfast on metabolic and neurofunctional responses in healthy individuals. J Diab. Res. 2017;2017:1–10.
   Web of Science ®Google Scholar
• Friedman NP, Robbins TW. The role of prefrontal cortex in cognitive control and executive function. Neuropsychopharmacology. 2022;47(1):72–89.
   PubMed Web of Science ®Google Scholar
• Butler PM, Chiong W. Neurodegenerative disorders of the human frontal lobes. Handb Clin Neurol. 2019;163:391–410.
   PubMedGoogle Scholar